PTPRG and Alzheimer disease: Genome-wide significant associations of AD risk with PTPRG was observed in a family-based GWAS56 and with CLNK in a recent large GWAS for which the evidence was derived almost entirely with a proxy AD phenotype in the UK Biobank57.